The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, giving PlexusDx providers actionable data to fine-tune your therapy and monitoring schedule
GLP-1 RAs in nonalcoholic fatty liver disease treatment Concurrent with the obesity epidemic, the prevalence of nonalcoholic fatty liver disease (NAFLD) has risen dramatically, becoming the most prevalent liver disorder in Western nations
I often remind clients that its not that the receptors break, but that the cell environment becomes overloaded and stressed
These include: Nausea, vomiting, and diarrhoea (very common, especially during dose escalation) Reduced appetite and abdominal discomfort Constipation Risk of hypoglycaemia when used with insulin or sulphonylureas Pancreatitis and gallbladder disease have been reported Thyroid C-cell tumours have been observed in animal studies, though the relevance to humans is unknown Important safety considerations when using both treatments include: Mounjaro can reduce the effectiveness of oral contraceptives due to delayed gastric emptying
Informed decision-making enables better adaptation while working towards your weight loss goals and navigating potential hurdles effectively
Individual results are not guaranteed and may vary
